Welcome to LookChem.com Sign In|Join Free

CAS

  • or

851028-60-9

Post Buying Request

851028-60-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851028-60-9 Usage

Molecular Structure

A complex organic compound derived from L-pyroglutamic acid with a formyl and a tert-butyl ester group attached to the 2-position of the pyrrolidine ring.

Usage in Industries

Commonly used in pharmaceutical and cosmetic industries as a building block for drug synthesis and as a moisturizing and anti-aging ingredient in skincare products.

Neuroprotective Properties

The compound has been studied for its potential neuroprotective properties, making it an area of interest for research in neuroscience and drug development.

Cognitive-Enhancing Properties

The compound has also been researched for its potential to enhance cognitive function, further contributing to its importance in the field of neuroscience.

Check Digit Verification of cas no

The CAS Registry Mumber 851028-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,0,2 and 8 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 851028-60:
(8*8)+(7*5)+(6*1)+(5*0)+(4*2)+(3*8)+(2*6)+(1*0)=149
149 % 10 = 9
So 851028-60-9 is a valid CAS Registry Number.

851028-60-9Relevant articles and documents

NOVEL SUBSTITUTED SULFONYLUREA DERIVATIVES

-

Page/Page column 36-37, (2020/07/31)

The present invention relates to novel heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as the compounds of the invention belong to the family of NOD-like receptor family (NLR) protein NLRP3 modulators. The present invention thus relates to novel NLRP3 modulators as well as to the use of the novel inhibitor compounds in the treatment of diseases or conditions in which interleukin 1β activity is implicated.

L-Proline derived nitrogenous steroidal systems: An asymmetric approach to 14-azasteroids

Singh, Ritesh,Panda, Gautam

, p. 19533 - 19544 (2013/10/22)

An efficient chiral pool approach using l-proline to access 14-azasteroids under mild reaction conditions has been described. The key step involves the intramolecular SN2′ cyclization reaction for the construction of critical C-ring in the nitrogen impregnated steroidal architectures bearing unsaturation at Δ9(11) position. In the endeavour to synthesize some new congeners, the remote electronic impact of the electron donating groups in A ring and heteroatoms like oxygen in B ring, on the propensity of C-ring cyclization was also observed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 851028-60-9